Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-02

FDA Approved: RUKOBIA — Original Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approved RUKOBIA (fostemsavir tromamine) via an original application to treat HIV-1 infection in adults with multidrug resistance, representing a new option…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rukobia (fostemsavir)

Snippet

ORIG AP for RUKOBIA (FOSTEMSAVIR TROMETHAMINE)